Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
It is a histamine analog used in the treatment of Ménière's vertigo without sufficient evidence of its efficacy (Strupp 2020, Rosenbaum 2017, Murdin 2016, Della 2006, James 2001). Oral administration.
At latest update, relevant information on excretion into breast milk was not found.
Because of pharmacokinetic data it is likely excretion into breast milk, but though from very low plasma levels, usually below the detection threshold (100 pg/mL), so it is unlikely that the amount that could reach breast milk is significant.
Potential side effects (nausea, dyspepsia, and headache) are mild and well tolerated. (Murdin 2016)
Consider other better known options, otherwise follow-up the child for symptoms like nausea, crying and fussiness. Waiting to breastfeed for 3 to 4 hours after taking betahistine minimizes passage into milk.